Abstract
We report an unusual clinical presentation of renal leiomyosarcoma. A woman, who received renal transplant from her mother, was diagnosed to have leiomyosarcoma in the donated kidney. The mother was found to have a right upper lobe lung mass 10 years later, which was diagnosed as leiomyosarcoma. It is possible that the mother had primary leiomyosarcoma of the donated kidney with micrometastases to the lung 10 years previously, which developed into a lesion in the donated kidney in her daughter. Ten years later, the slow-growing metastatic leiomyosarcoma developed into a lung mass.
Keywords: leiomyosarcoma; organ transplant; pulmonary; renal Background Leiomyosarcoma is a rare renal tumour. Smooth muscle tumours are extremely rare in solid organ transplant patients. We report an unusual clinical presentation of renal leiomyosarcoma.
Case report
A 64-year-old woman presented with cough and dyspnoea for 6 months. Ten years previously, the patient had donated a kidney to her daughter who had end-stage renal disease due to systemic lupus erythematosus. Chest radiograph of the patient was normal before donating her kidney. Two years after the renal transplant, the patient's daughter was found to have a lesion in the transplanted kidney during workup for proteinuria. The renal lesion biopsy of the daughter showed leiomyosarcoma, which was surgically resected (Figure 1) . Two months later, the patient's daughter had recurrence of leiomyosarcoma, which responded to further surgical resection and chemotherapy. The patient denied smoking and alcohol abuse.
Physical examination was normal. Routine blood tests including complete blood count and chemistry were normal. Chest X-ray was done which showed a right upper lobe lung mass (Figure 2 ). Positron emission tomography scan of the lungs showed increased uptake in the right upper lobe lung mass. The patient underwent wedge resection of the lung mass with mediastinal lymph node dissection.
Histopathology of the right lung mass showed lowgrade leiomyosarcoma without mediastinal lymph node involvement ( Figure 3) . A possible diagnosis of primary leiomyosarcoma of the kidney with solitary lung metastasis was made.
Discussion
Leiomyosarcoma is a rare renal tumour. Renal leiomyosarcoma, like other types of sarcomas, tend to displace rather than invade the parenchyma, and it is characterized by rapid growth rate, frequent metastasis and high local and systemic recurrence rates. High-grade sarcomas often metastasize, the lungs being the primary site of spread and prognosis is poor. The majority of patients die due to the progression of the disease within a matter of months. Low-grade sarcomas tend to pursue a more indolent course, although local recurrences are common. For the renal sarcomas, the best treatment modality is radical nephrectomy. Leiomyosarcomas, even when confined to the kidney, have a poor prognosis in general with 5-year survival rates of 29-36% [1] . In a case series on genitourinary leiomyosarcomas, the primary tumour site in 131 patients was the bladder in 20, the kidney in 26, paratesticular in 57, the prostate in 21 and other in seven. The most common histological subtypes were leiomyosarcoma in 29% of cases and liposarcoma in 26%. Seventy-eight percent of lesions were high grade [2] .
Smooth muscle tumours arising in recipients of solid organ transplants are rare, with only 14 cases reported in the English-language literature. Incidence of sarcomas is 1.7% in solid organ transplant patients. Epstein-Barr virus (EBV) infection has been implicated in the pathogenesis of these tumours because of diminished immune function due to immunosuppressive therapy [3] . Ferri et al. reported a 61-year-old woman who had a leiomyosarcoma arising in a bronchus 29 years after renal transplantation [4] . The presence of EBV was demonstrated in tumour tissue by in situ hybridization. The interval of 29 years represents the longest interval from transplant to tumour in the literature. Chay et al. reported a 46-year-old female who received a single renal transplantation 10 years earlier for treatment of IgA nephropathy and was maintained on a regimen of azathioprine, cyclosporine and prednisolone. She presented with bilateral basal lung nodules and endobronchial mass in the left mainstem bronchus. A biopsy of the mass showed EBV associated smooth muscle tumour [5] . Sarcomas in solid organ transplant patients appear to have aggressive features with 62% being high grade and 40% metastatic at the time of primary diagnosis with a recurrence rate of 30%. The development of the renal leiomyosarcoma was more aggressive in the patient's daughter, most likely due to her immunosuppressive therapy.
Primary thoracic leiomyosarcomas are rare and occur in the mediastinum, heart, lung, pulmonary artery and superior vena cava. These tumours usually occur in the sixth decade or later and are more common in men. Leiomyosarcomas located in the mediastinum typically manifest clinically as a result of local mass effect (e.g. pain, cough, superior vena cava syndrome). Patients with pulmonary artery sarcomas present with chest pain, dyspnoea or intractable congestive heart failure. Primary pulmonary leiomyosarcomas are often asymptomatic, but patients can present with haemoptysis. The best available treatment option is complete resection of the tumour, which is associated with a reported 5-year survival of 29 to 40% [6] . As these tumours are resistant to both chemotherapy and radiotherapy, adjuvant therapies are not very effective. The most consistent predictor of long-term survival is the grade of the tumour.
The clinical presentation of renal leiomyosarcoma in this case is unusual. It is possible that our patient had primary leiomyosarcoma of the donated kidney with micrometastases to the lung 10 years back, which developed into a lesion in the donated kidney in her daughter. The slow-growing low-grade leiomyosarcoma developed into a metastatic solitary lung mass 10 years later in the patient. The patient's daughter had more aggressive manifestation of leiomyosarcoma in the transplanted kidney due to immunosuppressive therapy. Other possibilities include: (i) the daughter had renal leiomyosarcoma secondary to immunosuppression and not 'donated' by the mother, or (ii) the mother had two different primary sites of leiomyosarcoma (donated kidney and lung). However, these are less likely possibilities in our opinion.
In conclusion, we report an unusual clinical presentation of renal leiomyosarcoma. We are not aware of a similar clinical presentation of renal leiomyosarcoma in the medical literature.
